chrisvoncsefalvay/vaers-outcomes huggingface dataset:
4-5 days after injection I started to notice my smell and taste being distorted almost all foods taste really strange and my smelling is just terrible I can?t even smell smoke anymore. Some cleaning agents have a heavy smell and sodas like  also have a  smell or taste to them. And certain foods I can?t taste or smell at  I have a small family so I do cook often but now it?s kind of  Hard to get the correct taste own my own family members have to sample the taste for me. And I also can smell my grand baby soiled diapers anymore  I also can?t smell me or my family members poops anymore.  My favorite foods I can?t enjoy anymore because of this
Ringing in ears; Ringing in ears become worse; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) in the left arm on 02Apr2021 at 10:30 (at the age of 36-years-old) and had received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) in the left arm on 30Apr2021 at 10:30 (at the age of 36-years-old) as a dose for COVID-19 immunisation. The patient had no medical history and known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ofloxacin otic Solution (MANUFACTURER UNKNOWN) and gummy bear vitamins (MANUFACTURER UNKNOWN); all for an unknown indication from an unknown date and unknown if ongoing. On an unknown date in Apr2021, may be three weeks after the first dose, the patient experienced ringing in ears. The patient had been having a very minor ear problem checked out during this time, but only for one ear and he had been using the Ofloxacin otic solution drops to help. But both ears had the ringing and after the second dose of the COVID-19 vaccine it had become worse. The patient was convinced that the vaccine did this and he could not make it stop. The event resulted in doctor or other healthcare professional office, clinic visit. Therapeutic measures were taken as a result of event ringing in ears which included the treatment with lipo-flavonoid pills (MANUFACTURER UNKNOWN) on an unknown date. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events ringing in ears and had become worse was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
2 days after injection pneumonia 23 stated had welts on arm and nasal cong. When she presented still had the welts but decreased in size. No other symptoms. To take BENADRYL 7/21 PM and 7/22 AM. To call 911 with any difficulty breathing or breaking out more.
Narrative: COVID infection following COVID vaccine series 03/16, Pfizer, dose #1 04/08 Pfizer, dose #2 09/05 pt cc: fatigue, headache, chills, cough, fever, myalgias exposure: unknown 09/13 COVID swab, result: detected 09/13 BinaxNOW COVID-19 AG: NOT detect
This case was reported by a consumer via call center representative and described the occurrence of adverse event in an adult patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced adverse event. On an unknown date, the outcome of the adverse event was unknown. It was unknown if the reporter considered the adverse event to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The reporter had spoken with the physician and she was told by the physician that the 2nd dose was worse than the 1st dose. The reporter stated that, the physician did not react at all after the 2nd dose. This case has been linked to the US2018102535 reported by the same reporter.
p/pt recv vax cried; within 30 sec pt became extremely pale, limp & hyporesponsive-pulse ox 99%,heart rate 138;remained pale & quiet  x15-20 min; cried, then went to sleep w/improved color; hosp overnight; neurologist to see pt; nl exam at
Patient  had a flu shot in December.  He had issues with his shoulder and not being able to lift his arm to even shoulder height so he went to the Dr. and they gave him a steroid shot.  The told him it was from his flu shot being in the wrong area and too high.  The mentioned ?cerva? and told him to monitor it as it could end up being serious  They also said it was like a bersa that was inflamed due to the location of the shot.
States she had the shot in the morning, states in the evening she had a stiff neck that radiated down into her R side (the side she got her shot on). States she went to bed and woke up at about 3 a.m. and she was so sick vomiting/dry heaves (2-3) and having diarrhea (approx 3). She also had chills. States she could hardly use her R hand. States her wrist is just now getting better. She notes she was able to walk but she was very careful. She did not try to speak. She does not have residual symptoms other than some residual stiffness. She had to use her rescue inhaler the morning prior to the vaccine, and again in the evening after the vaccine.
Breakthrough case admission after 3 vaccines Modern 1/23/21 lot4 029l20a;  mODERN 2/27/21 LOT# 002a21a;  mODERNA 11/28/21 LOT# 030h21b
Initial report received on 28 April 2008 from another manufacturer, report# WAES 0804USA04043.  The initial reporter to this manufacturer had been a health care professional.  Verbatim from the report: "Information has been received from a physician concerning a 16 year old female with no medical history and an allergy to naproxen, who on 17-JAN-2008 was vaccinated IM in one arm with a dose of Gardasil (Lot# 659653/1448U) and a dose of MENACTRA, administered in the other arm.  On approximately 01-FEB-2008, fifteen days post vaccination, the patient developed a rash.  The rash was predominantly on the neck and the face.  The rash was diffuse, macular, itchy, and was hive-like in some areas.  The patient complained of a marked lack of energy and several episodes of wheezing and respiratory discomfort.  On 05-FEB-2008 the patient went to the emergency room because she was experiencing difficulty breathing, headache, and a swelling sensation in the throat.  The patient was diagnosed with allergic reaction and/or exercise induced asthma.  The patient was treated with albuterol and an unspecified steroid.  On 07-FEB-2008 the patient went to the emergency room because she experienced difficulty breathing after taking her inhaler for two days and the steroid for one day.  The patient was diagnosed with atypical pneumonia and treated with ZITHROMAX.  On 15-FEB-2008 the patient was seen for back pain and "choleretic pain."  The shortness of breath had resolved.  The patient's chest x-ray had no change.  The patient had positive convalescent mycoplasma.  On 04-MAR-2008 the patient followed up at the office to recheck the pneumonia and upper respiratory infection, which were resolved.  It was reported that the patient's back pain was 80% better.  The blood counts were normal.  On 07-MAR-2008 the patient was seen by her primary pediatrician.  It was reported that the patient may have used ALEVE during the week for relief of pain.  It was reported that there was no wheezing, lungs were cleared, and the patient was referred to an allergist.  The patient was started on FLOVENT.  On 11-MAR-2008 there was a call to the office for an unspecified reason.  The patient was prescribed an EPIPEN.  On 12-MAR-2008 the patient saw an allergist who said that her pulmonary functions were normal.  The allergist did not think that the patient required respiratory medications.  On 10-APR-2008 the patient came back to the office due to a cold, and complained of a headache, dizziness, and vertigo.  The patient had no other neurological conditions.  The patient had experienced persistent malaise and fatigue since the onset of the rash.  At the time of the report, the patient was not recovered from all events.  No product quality complaint was involved.  Upon internal review the allergic reaction, exercise induce asthma, difficulty breathing, headache, swelling sensation in throat, and atypical pneumonia were considered to be other important medical events.  Additional information has been requested."
pins and needles feel starting in heels and moving across legs and arms. It has been a week and pt is still feeling periodically the numbness and pins and needles in the left arm where the shot was given.
This spontaneous report was received from a other health professional (nurse) regarding a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant medications and drug/allergies were not reported. On 12-DEC-2018, the patient was vaccinated with improperly stored RECOMBIVAX HB (dose, route of administration not reported) lot # R006746 and expiration date: 09-NOV-2020 for prophylaxis. No adverse event was reported. Temperature was reported as  9°C to 25 °C with a time frame of 1.5 hours. There was no previous temperature excursion. Digital data logger was present. This is one of several reports received from the same reporter.
Almost complete loss of mobility in left arm starting at 4 hrs after. Severe painful muscle contracting. It is now 45 hrs after shot and I still cannot move or use my arm much at all- needing help for any simple tasks like dressing myself.
sent to the emergency room for body rashes and hives.; sent to the emergency room for body rashes and hives.; This is a spontaneous report from a contactable pharmacist. This pharmacist reported same events for 4 patients. This is the 4th of four reports. A patient of unspecified age and gender received BNT162B2 via an unspecified route of administration, on an unspecified date at single dose for immunization. Medical history included allergies to bee stings. It was reported that the patient sent to the emergency room post vaccine for body rashes and hives. There seemed to be a commonality of allergies to bee stings for the 4 different individuals. The pharmacist wondered if there are other reports of this. They are recommending that those with a bee sting allergy hold off until knowing more and wondered if any guidance from Pfizer. Event took place after use of product. Outcome of the events was unknown.   Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2020502532 same reporter, drug, event but different patient
patient report pain in shoulder moving down side to hip and upper leg, over a few day in started restricting arm movement, and remained painful. slow recovery was reported in a few day, but motion was still restricted
It locked up my chest or lungs and I couldn't suck in air to breathe. I called 911 and all my vitals checked out fine and after a while, I was able to breathe normal again.
Patient felt lightheadedness and flushed when he was waiting during his 15 minute post vaccination time.
Patient was dizzy, nauseous, sweating after 15mts of getting the vaccine. He drank bottled water and had a sucker. After a while ,he was feeling better.
Pain in site of vaccine injection, started on the day of vaccine and continued through the date of this report (4 weeks later).
Eight days post vaccine I developed an itchy, hive like rash over the injection site.  It was approximately the size of a baseball in diameter.  Over the next two days the itching and hives disappeared but the redness expanded in size.  By the third day all symptoms were gone.
No Adverse event happened. Patient asked for  the monovalent pfizer booster vaccine since patient did not want to come back next week for the bivalent Pfizer booster vaccine.  Pharmacy administered the monovalent without being aware of the guideline changed recently.
Case reported no Covid symptoms at all, (asymptomatic).  Case was tested prior to the insertion of a heart Stent 02/11/2022. Case remained in hospital 1 day following the heart procedure.
Ten days after vaccination, I started having eye floaters and impaired vision in my right eye, no pain. This continued for 1 month and I went to see two different eye doctors. I was diagnosed with retinal tear. No medications were prescribed. I did not have any eye problems with my last eye doctor appointment shortly prior to my first vaccination. I have had multiple visits for follow up. I was told I need to either have eye surgery or just to watch it and see if it heals on its own. We chose to just watch the eye condition at this time.
Generalized rash at focal site.  How grade.  Temperature-sleeping poorly x 3 days.  Prescribed : advil/tylenol, antipyrectics-Benadryl PO.
PT is not yet eligible for the booster shot. Mom did not know and we failed to catch it. PT will be eligible in 1 week exactly. We let mom know when we realized it but she was not concerned and did not feel the need for us to contact the doctor. 7 hours after the vaccine when I spoke with mom she reported that pt is doing fine. We will check in with her tomorrow as well.
Chickenpox, onset 2/26/2000. Treated with Zovirax, Benadryl, Tylenol vs ibuprofen, aveeno baths, Bactroban ointment.
pt states thats, the night of getting flu shot and prevnar she experiened high fever,night sweats. nothing else was reported. pt states that she did not take any medication and it went away the next day.
After waiting 15 minutes and left vaccination site with my husband. About 10 minutes later, sudden feeling of throat closing, shortness of breath and racing heart
Rash, itching starting on neck and arms progressed to blistering continues to spread over body.
Adult blaschkitis. Cluster of raised pink papules on collarbone area.  Untreatable. Had it for 6 months. Itchy at times and scaly appearance.
Sore arm; headache; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA; Lot Number: EN5318), via an unspecified route of administration in the left arm on 23Mar2021 at 13:45 (at the age of 53-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food or other products. Concomitant medications included calcium (MANUFACTURER UNKNOWN), multivitamin supplements (MANUFACTURER UNKNOWN), ibuprofen (MANUFACTURER UNKNOWN); all from unknown dates for unspecified indications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA; Lot Number: EN5318), via an unspecified route of administration in the left arm on 02Mar2021 at 08:00 (at the age of 53-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 25Mar2021 at 12:00, the patient experienced sore arm and headache. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events sore arm and headache was recovered on unspecified date in Mar2021.  No follow-up attempts are needed. No further information is expected.
First dose on 4-FEB-2021 and second dose on 24-MAR-2021; This spontaneous case was reported by a patient and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 4-FEB-2021 and second dose on 24-MAR-2021) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure and Penicillin allergy.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 4-FEB-2021 and second dose on 24-MAR-2021). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 4-FEB-2021 and second dose on 24-MAR-2021) outcome was unknown.            Concomitant drugs were not reported.  Treatment details were not given.   This case was linked to MOD-2022-582887 (Patient Link).
Reported tingling tongue. Took own benadryl, monitored for 15 mins, noted resolution of symptoms and d/c home,
client received varicella vaccine on 08/16/2005. Today it is reported 3 days ago area on left arm began itching on exam there is redness swelling with a lesion in the center of the redness. Left arm is warm to touch. There is a lesion on right upper lip that appeared 2 days ago. Referred to MD for evaluation.
Lower back pain started early morning after immunization, progressing during the day. Fever 3/5/02 eve. up to 101 degree F. He took acetaminophen to help with pain and fever-developed into chest cold on 3/7/2002.
Chills  and then got hot with headache along with being very tired lasting  about 14 hours
Pneumonia; patient was put in an induced coma; alpha strain of flu; H1N1 flu; Initial information received on 08-Dec-2020 regarding an unsolicited valid serious social media case received from a consumer (patient) via social media.  This case is linked to case 2020SA355629.  This case involves a patient of an unknown demography who experienced pneumonia, had alpha strain of flu (influenza) and H1N1 flu (H1N1 influenza), and underwent induced coma (medical induction of coma) after receiving INFLUENZA VACCINE.  The patient's medical history, medical treatments, vaccinations, concomitant medications and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiry date not reported) via an unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient experienced a serious pneumonia 4 months following the administration of INFLUENZA VACCINE. This event was assessed as medically significant.  On an unknown date, the patient was put in an induced coma (medical induction of coma), had alpha strain of flu (influenza) and H1N1 flu (H1N1 influenza) 4 months following the administration of INFLUENZA VACCINE.  It was reported that some peoples bodies will overreact to the vaccine by working too hard to create antibodies to the dead flu injected, thus weakening the immune system, and leaving the body without protection to other strains of flu. The patient never had a problem in life catching the flu. Not until he/she got a vaccine. Have not had it since, either. Needless to say, the reporter would not get any more flu vaccines. It may work for others and it is not healthy for everyone.  Relevant laboratory test results included: Influenza A virus test on an unknown date was positive.  It was not reported if the patient received a corrective treatment.  The events outcome was unknown, at the time of reporting.  Information on the batch number was requested.; Sender's Comments: This case involves a patient who experienced pneumonia, alpha strain of flu (influenza) and H1N1 influenza, had medical induction of coma while he/she received INFLUENZA VACCINE.Time to onset is compatible. However, additional information on patients medical condition at the time of vaccination, concomitant medication and investigations ruling out other etiologies would be needed for complete assessment of the case. Based upon the reported information, the role of the vaccine cannot be assessed.
Pt stated had chills, v/s were taken BP: 120/60 Heart rate 136. Pt was laid down and v/s taken before going home BP: 110/60 Heart rate 80.
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter(s) (Physician). The reporter is the patient.  An 81-year-old male patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Antiviral details: COVID 19 Treatment with Paxlovid from 31Jan2023 till 04Feb2023. No known allergies.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: The efficacy of a drug varies from patient to patient and can be affected by different factors; however, a contributory role of the suspect product bnt162b2 to the reported drug ineffective / COVID-19 cannot be ruled out
Arrested 1 1/2 hrs post inject; resuscitated & put on respirator; 24 hrs later MD discusssed w/parents about d/c life support because pt multiple problems & was non-responsive to current tx; Life support systems d/c pt allowed to die;
pt admitted to hospital with COVID pneumonia; AHRF; placed on Vapotherm initially then progressed to BiPAP due to increasing O2 need; DNI; pt didn't like BiPAP and requested it to be removed; condition deteriorated and pt was made comfort measures with comfort medications made available; pt passed away in the hospital
Information has been received from a Registered Nurse referring to a patient of unknown age and gender. Information about patient's concurrent conditions and medical history was not reported. On 14-JUL-2015 the patient was inadvertently vaccinated with a dose of improperly stored ROTATEQ (dose not reported, lot # K010325 with expiration date 10-MAY-2016, orally). Concomitant medications were not provided. No adverse effects were reported. Additional information has been requested.
3/31/2021: Patient was observed post COVID-19 immunization for 30 minutes based on pre-vaccination screening. During the observation period, he experienced an adverse reaction with the following symptoms: Tingling and swelling of face and throat. Tightening sensation to the face including mouth. Sweating, with redness to the face. Mild nonproductive cough.  Assessment : Time of assessment 0932am. Alert and oriented. Nurse assessed lung sounds, VS monitored for 30 minutes.   Actions taken: assessment of face and mouth, no swelling seen, face is red and he has sweating forehead.  Vitals sign taken at 0932 with BP- 185/131, P- 89. R-17 O2- 98% , Benadryl 12.5 mg liquid given po x 1, VS rechecked at 0937, BP - 190/134, P- 84, T- 98.4. R- 18, O2- 98%, Benadryl 12.5 liquid given PO at 0927. EMS on site due to another issue, assessed pts lung sounds and assessed for auditory stridor to neck, patient with slight cough, voices that he is feeling some better, he remains sitting in wheelchair. VS at 0947 , BP- 166/127, P- 82. O2- 98%, VS at 1002- BP_ 154/110, P- 85, O2- 96%.       Medications administered: Diphenhydramine (Benadryl) 12.5 ml (25 mg) by mouth. Time: 0932 and 0937. Administered by RN.   Disposition:Reports swelling to face and mouth has improved, he is advised to follow up with PCP for elevated BP AND SYMPTOMS ASSOCIATED WITH VACCINE/   Immunizations Administered    Name Date Dose VIS Date Route   Pfizer COVID-19 Vaccine 3/31/2021  9:08 AM 0.3 mL 12/11/2020 Intramuscular
Patient  says she experienced chills for 4-5 days and took tylenol for relief and was also sick to her stomach
Shot 3JAN92 pt started running fever 4JAN92 fever gradually elevating  hi 105 R; pt had sz & was taken to ER; ER MD felt sz result of hi fever; Also on that day pt came down w/bad cold;